Press releases
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Key statistics
On Friday, Aethlon Medical Inc (EJU0:MUN) closed at 0.56, 37.25% above the 52 week low of 0.408 set on Jun 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.56 |
---|---|
High | 0.56 |
Low | 0.56 |
Bid | 0.530 |
Offer | 0.555 |
Previous close | 0.745 |
Average volume | 15.67k |
---|---|
Shares outstanding | 5.05m |
Free float | 4.88m |
P/E (TTM) | -- |
Market cap | 2.07m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 07:05 BST.
More ▼